Linda Venters Email and Phone Number

Market development prior to product release for heart failure and cardiovascular disease in Eastern Washington and Western Montana. Identified key opinion leaders and office personal, sought potential speakers, evaluated prospective accounts, office access & policies, assessed hospital relevance for the products, Primary targets were cardiology and endocrinology. Participated in two product launches.• First prescriptions in district and led the district in heart failure prescriptions thru September.• Planned & executed several new product programs in areas crucial to product success• ACC Certification OHSU 92% passing score• Compliance point for district• Accrued performance points thru out the year for leadership within the district, product performance

Promoted a diverse line of oncology products in Eastern Washington and Idaho. Key strategic relationships with customers and decision-making pharmacist insured formulary review and product acceptance at largest Eastern Washington account. As a speaker liaison, cultivated and advanced melanoma speaker thru out the division nationally. • Converted largest account in Spokane from an oral account to an IV account; 2011 sales $57,344 2012 sales $280,827 (Oct 2012); year-over-year growth for this account as of 11-9-2012 at 153.1%• Primary product growth rate YTD 2012 157% (WA)• Acting speaker liaison for Melanoma 2010-2012• New product launch demonstrating continued growth throughout 2012

Hospital position which involved intense formulary competition. Two of three products gained formulary acceptance on all hospital formularies within my territory; my products were not displaced or replaced until I left the division. Avoided product replacement in my largest account during a year long product shortage. Established relationships with key decisions makers at all levels in the hospital, which lead to increased business opportunities. Promoted to Senior Executive Specialty Representative based on leadership skills, exceeding territory goals, company & community contribution. Top 5% of entire sales force.• 2009 Nov YTD three largest hospitals 192%, 56% and 60% growth for primary product• 2008 Antibiotic growth 70%, Antifungal 2008 40%; primary product- 80% growth• 2008 Growth above the region and nation for all products- 124-127%; growth 21-41%• 2007 Antibiotic growth 21% Antifungal 41%• Responsible for several hospital formulary additions in 2007 and 2008